Simon Edvardson1, Jae Kyo Yi2, Chaim Jalas3, Ruijuan Xu4, Bryn D Webb5, Justin Snider6, Anastasia Fedick7, Elisheva Kleinman3, Nathan R Treff7, Cungui Mao4, Orly Elpeleg1. 1. The Monique and Jacques Roboh Department of Genetic Research, Hadassah, Hebrew University Medical Center, Jerusalem, Israel. 2. Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA Department of Medicine, Stony Brook University, Stony Brook, New York, USA Stony Brook Cancer Center, Stony Brook, New York, USA. 3. Bonei Olam, Center for Rare Jewish Genetic Disorders, Brooklyn, New York, USA. 4. Department of Medicine, Stony Brook University, Stony Brook, New York, USA Stony Brook Cancer Center, Stony Brook, New York, USA. 5. Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 6. Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA Department of Medicine, Stony Brook University, Stony Brook, New York, USA. 7. Departments of Molecular Genetics, Microbiology and Immunology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey, USA Reproductive Medicine Associates of New Jersey, Morristown, New Jersey, USA.
Abstract
BACKGROUND/AIMS: Leukodystrophies due to abnormal production of myelin cause extensive morbidity in early life; their genetic background is still largely unknown. We aimed at reaching a molecular diagnosis in Ashkenazi-Jewish patients who suffered from developmental regression at 6-13 months, leukodystrophy and peripheral neuropathy. METHODS: Exome analysis, determination of alkaline ceramidase activity catalysing the conversion of C18:1-ceramide to sphingosine and D-ribo-C12-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) (NBD)-phytoceramide to NBD-C12-fatty acid using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and thin layer chromatography, respectively, and sphingolipid analysis in patients' blood by LC-MS/MS. RESULTS: The patients were homozygous for p.E33G in the ACER3, which encodes a C18:1-alkaline ceramidase and C20:1-alkaline ceramidase. The mutation abolished ACER3 catalytic activity in the patients' cells and failed to restore alkaline ceramidase activity in yeast mutant strain. The levels of ACER3 substrates, C18:1-ceramides and dihydroceramides and C20:1-ceramides and dihydroceramides and other long-chain ceramides and dihydroceramides were markedly increased in the patients' plasma, along with that of complex sphingolipids, including monohexosylceramides and lactosylceramides. CONCLUSIONS: Homozygosity for the p.E33G mutation in the ACER3 gene results in inactivation of ACER3, leading to the accumulation of various sphingolipids in blood and probably in brain, likely accounting for this new form of childhood leukodystrophy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND/AIMS: Leukodystrophies due to abnormal production of myelin cause extensive morbidity in early life; their genetic background is still largely unknown. We aimed at reaching a molecular diagnosis in Ashkenazi-Jewish patients who suffered from developmental regression at 6-13 months, leukodystrophy and peripheral neuropathy. METHODS: Exome analysis, determination of alkaline ceramidase activity catalysing the conversion of C18:1-ceramide to sphingosine and D-ribo-C12-N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) (NBD)-phytoceramide to NBD-C12-fatty acid using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and thin layer chromatography, respectively, and sphingolipid analysis in patients' blood by LC-MS/MS. RESULTS: The patients were homozygous for p.E33G in the ACER3, which encodes a C18:1-alkaline ceramidase and C20:1-alkaline ceramidase. The mutation abolished ACER3 catalytic activity in the patients' cells and failed to restore alkaline ceramidase activity in yeast mutant strain. The levels of ACER3 substrates, C18:1-ceramides and dihydroceramides and C20:1-ceramides and dihydroceramides and other long-chain ceramides and dihydroceramides were markedly increased in the patients' plasma, along with that of complex sphingolipids, including monohexosylceramides and lactosylceramides. CONCLUSIONS: Homozygosity for the p.E33G mutation in the ACER3 gene results in inactivation of ACER3, leading to the accumulation of various sphingolipids in blood and probably in brain, likely accounting for this new form of childhood leukodystrophy. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: J Koch; S Gärtner; C M Li; L E Quintern; K Bernardo; O Levran; D Schnabel; R J Desnick; E H Schuchman; K Sandhoff Journal: J Biol Chem Date: 1996-12-20 Impact factor: 5.157
Authors: Kai Wang; Ruijuan Xu; Jennifer Schrandt; Prithvi Shah; Yong Z Gong; Chet Preston; Louis Wang; Jae Kyo Yi; Chih-Li Lin; Wei Sun; Demetri D Spyropoulos; Soyoung Rhee; Mingsong Li; Jie Zhou; Shaoyu Ge; Guofeng Zhang; Ashley J Snider; Yusuf A Hannun; Lina M Obeid; Cungui Mao Journal: PLoS Genet Date: 2015-10-16 Impact factor: 5.917
Authors: Devesh C Pant; Imen Dorboz; Agatha Schluter; Stéphane Fourcade; Nathalie Launay; Javier Joya; Sergio Aguilera-Albesa; Maria Eugenia Yoldi; Carlos Casasnovas; Mary J Willis; Montserrat Ruiz; Dorothée Ville; Gaetan Lesca; Karine Siquier-Pernet; Isabelle Desguerre; Huifang Yan; Jingmin Wang; Margit Burmeister; Lauren Brady; Mark Tarnopolsky; Carles Cornet; Davide Rubbini; Javier Terriente; Kiely N James; Damir Musaev; Maha S Zaki; Marc C Patterson; Brendan C Lanpher; Eric W Klee; Filippo Pinto E Vairo; Elizabeth Wohler; Nara Lygia de M Sobreira; Julie S Cohen; Reza Maroofian; Hamid Galehdari; Neda Mazaheri; Gholamreza Shariati; Laurence Colleaux; Diana Rodriguez; Joseph G Gleeson; Cristina Pujades; Ali Fatemi; Odile Boespflug-Tanguy; Aurora Pujol Journal: J Clin Invest Date: 2019-02-11 Impact factor: 14.808
Authors: Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang Journal: Cell Mol Life Sci Date: 2018-12-06 Impact factor: 9.261
Authors: Piming Zhao; Isaac D Liu; Jeffrey B Hodgin; Peter I Benke; Jeremy Selva; Federico Torta; Markus R Wenk; James A Endrizzi; Olivia West; Weixing Ou; Emily Tang; Denise Li-Meng Goh; Stacey Kiat-Hong Tay; Hui-Kim Yap; Alwin Loh; Nicole Weaver; Bonnie Sullivan; Austin Larson; Megan A Cooper; Khalid Alhasan; Abdullah A Alangari; Suha Salim; Evren Gumus; Karin Chen; Martin Zenker; Friedhelm Hildebrandt; Julie D Saba Journal: J Inherit Metab Dis Date: 2020-05-04 Impact factor: 4.982
Authors: Hadley Stevens Smith; J Michael Swint; Seema R Lalani; Jose-Miguel Yamal; Marcia C de Oliveira Otto; Stephan Castellanos; Amy Taylor; Brendan H Lee; Heidi V Russell Journal: Genet Med Date: 2018-05-14 Impact factor: 8.822